These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24832167)

  • 1. Fibulin-1 predicts disease progression in patients with idiopathic pulmonary fibrosis.
    Jaffar J; Unger S; Corte TJ; Keller M; Wolters PJ; Richeldi L; Cerri S; Prêle CM; Hansbro PM; Argraves WS; Oliver RA; Oliver BG; Black JL; Burgess JK
    Chest; 2014 Oct; 146(4):1055-1063. PubMed ID: 24832167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of serum S100 calcium-binding protein A4 in idiopathic pulmonary fibrosis.
    Akiyama N; Hozumi H; Isayama T; Okada J; Sugiura K; Yasui H; Suzuki Y; Kono M; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Suda T
    Respirology; 2020 Jul; 25(7):743-749. PubMed ID: 31597225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis.
    Naik PK; Bozyk PD; Bentley JK; Popova AP; Birch CM; Wilke CA; Fry CD; White ES; Sisson TH; Tayob N; Carnemolla B; Orecchia P; Flaherty KR; Hershenson MB; Murray S; Martinez FJ; Moore BB;
    Am J Physiol Lung Cell Mol Physiol; 2012 Dec; 303(12):L1046-56. PubMed ID: 23043074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFβ1.
    Estany S; Vicens-Zygmunt V; Llatjós R; Montes A; Penín R; Escobar I; Xaubet A; Santos S; Manresa F; Dorca J; Molina-Molina M
    BMC Pulm Med; 2014 Jul; 14():120. PubMed ID: 25064447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of CD248 as a potential severity marker in idiopathic pulmonary fibrosis.
    Bartis D; Crowley LE; D'Souza VK; Borthwick L; Fisher AJ; Croft AP; Pongrácz JE; Thompson R; Langman G; Buckley CD; Thickett DR
    BMC Pulm Med; 2016 Apr; 16(1):51. PubMed ID: 27080864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Significance of Cold-Inducible RNA-Binding Protein in Idiopathic Pulmonary Fibrosis.
    Hozumi H; Kataoka K; Kondoh Y; Isayama T; Okada J; Sugiura K; Mori K; Kono M; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Suda T
    Chest; 2021 Dec; 160(6):2149-2157. PubMed ID: 34252438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
    Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
    J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis.
    O'Dwyer DN; Armstrong ME; Trujillo G; Cooke G; Keane MP; Fallon PG; Simpson AJ; Millar AB; McGrath EE; Whyte MK; Hirani N; Hogaboam CM; Donnelly SC
    Am J Respir Crit Care Med; 2013 Dec; 188(12):1442-50. PubMed ID: 24070541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased AGE-RAGE ratio in idiopathic pulmonary fibrosis.
    Machahua C; Montes-Worboys A; Llatjos R; Escobar I; Dorca J; Molina-Molina M; Vicens-Zygmunt V
    Respir Res; 2016 Nov; 17(1):144. PubMed ID: 27816054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis.
    Bocchino M; Agnese S; Fagone E; Svegliati S; Grieco D; Vancheri C; Gabrielli A; Sanduzzi A; Avvedimento EV
    PLoS One; 2010 Nov; 5(11):e14003. PubMed ID: 21103368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Expressed Macrophage Scavenger Receptor 1 Predicts Severity Clinical Outcome in Transplant Patient in Idiopathic Pulmonary Fibrosis Disease.
    Zheng M; Tian T; Liang J; Ye S; Chen J; Ji Y
    J Immunol Res; 2021; 2021():6690100. PubMed ID: 33604393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distal Lung Microenvironment Triggers Release of Mediators Recognized as Potential Systemic Biomarkers for Idiopathic Pulmonary Fibrosis.
    Kalafatis D; Löfdahl A; Näsman P; Dellgren G; Wheelock ÅM; Elowsson Rendin L; Sköld M; Westergren-Thorsson G
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LTBP2 is secreted from lung myofibroblasts and is a potential biomarker for idiopathic pulmonary fibrosis.
    Enomoto Y; Matsushima S; Shibata K; Aoshima Y; Yagi H; Meguro S; Kawasaki H; Kosugi I; Fujisawa T; Enomoto N; Inui N; Nakamura Y; Suda T; Iwashita T
    Clin Sci (Lond); 2018 Jul; 132(14):1565-1580. PubMed ID: 30006483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis.
    DePianto DJ; Chandriani S; Abbas AR; Jia G; N'Diaye EN; Caplazi P; Kauder SE; Biswas S; Karnik SK; Ha C; Modrusan Z; Matthay MA; Kukreja J; Collard HR; Egen JG; Wolters PJ; Arron JR
    Thorax; 2015 Jan; 70(1):48-56. PubMed ID: 25217476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene profile of fibroblasts identify relation of CCL8 with idiopathic pulmonary fibrosis.
    Lee JU; Cheong HS; Shim EY; Bae DJ; Chang HS; Uh ST; Kim YH; Park JS; Lee B; Shin HD; Park CS
    Respir Res; 2017 Jan; 18(1):3. PubMed ID: 28057004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibulin-1c regulates transforming growth factor-β activation in pulmonary tissue fibrosis.
    Liu G; Cooley MA; Jarnicki AG; Borghuis T; Nair PM; Tjin G; Hsu AC; Haw TJ; Fricker M; Harrison CL; Jones B; Hansbro NG; Wark PA; Horvat JC; Argraves WS; Oliver BG; Knight DA; Burgess JK; Hansbro PM
    JCI Insight; 2019 Jul; 5(16):. PubMed ID: 31343988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100A12 as Biomarker of Disease Severity and Prognosis in Patients With Idiopathic Pulmonary Fibrosis.
    Li Y; He Y; Chen S; Wang Q; Yang Y; Shen D; Ma J; Wen Z; Ning S; Chen H
    Front Immunol; 2022; 13():810338. PubMed ID: 35185901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
    Zhang L; Li Y; Liang C; Yang W
    Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibulin1C peptide induces cell attachment and extracellular matrix deposition in lung fibroblasts.
    Ge Q; Chen L; Jaffar J; Argraves WS; Twal WO; Hansbro P; Black JL; Burgess JK; Oliver B
    Sci Rep; 2015 Apr; 5():9496. PubMed ID: 25834989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum CA 15-3 is increased in pulmonary fibrosis.
    Ricci A; Mariotta S; Bronzetti E; Bruno P; Vismara L; De Dominicis C; Laganà B; Paone G; Mura M; Rogliani P; Mastrangeldo M; Sciacchitano S; Saltini C
    Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul; 26(1):54-63. PubMed ID: 19960789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.